The report just released from the United Nations’ High-Level Panel on Access to Medicines is not only misguided, but also a missed opportunity. Rather than the panel focusing on the real barriers of ineffectual health systems and limited resources, the report tramples on intellectual property protections on medicines. As a leading proponent of free markets in Europe I urge the UN that this initiative not be a continuity of work for the next Secretary General.”

The views expressed on are not necessarily those of the Austrian Economics Center.